Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:1530-1535
Published online before print August 26, 2002, doi: 10.1161/01.CIR.0000028811.03056.BF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/12/1530    most recent
01.CIR.0000028811.03056.BFv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arkenbout, E. K.
Right arrow Articles by de Vries, C. J.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arkenbout, E. K.
Right arrow Articles by de Vries, C. J.M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice

(Circulation. 2002;106:1530.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Protective Function of Transcription Factor TR3 Orphan Receptor in Atherogenesis

Decreased Lesion Formation in Carotid Artery Ligation Model in TR3 Transgenic Mice

E. Karin Arkenbout, MD; Vivian de Waard, PhD; Maaike van Bragt, BSc; Tanja A.E. van Achterberg, BSc; Jos M. Grimbergen, BSc; Bruno Pichon, PhD; Hans Pannekoek, PhD; Carlie J.M. de Vries, PhD

From the Department of Biochemistry (E.K.A., V.d.W., M.v.B., T.A.E.v.A., H.P., C.J.M.d.V.), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Gaubius Laboratory (J.M.G.), Leiden, the Netherlands; and ULB-IBMM-IRIBHN (B.P.), Gosselies, Belgium.

Correspondence to C.J.M. de Vries, PhD, Department of Biochemistry, Academic Medical Center, K1-163, Meibergdreef 15, 1105 AZ Amsterdam, Netherlands. E-mail c.j.devries@ amc.uva.nl

Background— Smooth muscle cells (SMCs) play a key role in intimal thickening in atherosclerosis and restenosis. The precise signaling pathways by which the proliferation of SMCs is regulated are largely unknown. The TR3 orphan receptor, the mitogen-induced nuclear orphan receptor (MINOR), and the nuclear receptor of T cells (NOT) are a subfamily of transcription factors belonging to the nuclear receptor superfamily and are induced in activated SMCs. In this study, we investigated the role of these transcription factors in SMC proliferation in atherogenesis.

Methods and Results— Multiple human vascular specimens at distinct stages of atherosclerosis (lesion types II to V by American Heart Association classification) derived from 14 different individuals were studied for expression of these transcription factors. We observed expression of TR3, MINOR, and NOT in neointimal SMCs, whereas no expression was detected in medial SMCs. Adenovirus-mediated expression of a dominant-negative variant of TR3, which suppresses the transcriptional activity of each subfamily member, increases DNA synthesis and decreases p27Kip1 protein expression in cultured SMCs. We generated transgenic mice that express this dominant-negative variant or full-length TR3 under control of a vascular SMC-specific promoter. Carotid artery ligation of transgenic mice that express the dominant-negative variant of TR3 in arterial SMCs, compared with lesions formed in wild-type mice, results in a 3-fold increase in neointimal formation, whereas neointimal formation is inhibited 5-fold in transgenic mice expressing full-length TR3.

Conclusions— Our results reveal that TR3 and possibly other members of this transcription factor subfamily inhibit vascular lesion formation. These transcription factors could serve as novel targets in the treatment of vascular disease.


Key Words: muscle, smooth • atherosclerosis • genes




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. A. Pearen, S. A. Myers, S. Raichur, J. G. Ryall, G. S. Lynch, and G. E. O. Muscat
The Orphan Nuclear Receptor, NOR-1, a Target of {beta}-Adrenergic Signaling, Regulates Gene Expression that Controls Oxidative Metabolism in Skeletal Muscle
Endocrinology, June 1, 2008; 149(6): 2853 - 2865.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. C. Chao, Z. Zhang, L. Pei, T. Saito, P. Tontonoz, and P. F. Pilch
Nur77 Coordinately Regulates Expression of Genes Linked to Glucose Metabolism in Skeletal Muscle
Mol. Endocrinol., September 1, 2007; 21(9): 2152 - 2163.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. M.M. Pires, T. W.H. Pols, M. R. de Vries, C. M. van Tiel, P. I. Bonta, M. Vos, E. K. Arkenbout, H. Pannekoek, J. W. Jukema, P. H.A. Quax, et al.
Activation of Nuclear Receptor Nur77 by 6-Mercaptopurine Protects Against Neointima Formation
Circulation, January 30, 2007; 115(4): 493 - 500.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. I. Bonta, C. M. van Tiel, M. Vos, T. W.H. Pols, J. V. van Thienen, V. Ferreira, E. K. Arkenbout, J. Seppen, C. A. Spek, T. van der Poll, et al.
Nuclear Receptors Nur77, Nurr1, and NOR-1 Expressed in Atherosclerotic Lesion Macrophages Reduce Lipid Loading and Inflammatory Responses
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2288 - 2288.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Schepers, D. Eefting, P.I. Bonta, J.M. Grimbergen, M.R. de Vries, V. van Weel, C.J. de Vries, K. Egashira, J.H. van Bockel, and P.H.A. Quax
Anti-MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2063 - 2069.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. de Waard, E. K. Arkenbout, M. Vos, A. I.M. Mocking, H. W.M. Niessen, W. Stooker, B. A.J.M. de Mol, P. H.A. Quax, E. N.T.P. Bakker, E. VanBavel, et al.
TR3 Nuclear Orphan Receptor Prevents Cyclic Stretch-Induced Proliferation of Venous Smooth Muscle Cells
Am. J. Pathol., June 1, 2006; 168(6): 2027 - 2035.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Pei, A. Castrillo, and P. Tontonoz
Regulation of Macrophage Inflammatory Gene Expression by the Orphan Nuclear Receptor Nur77
Mol. Endocrinol., April 1, 2006; 20(4): 786 - 794.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Pei, A. Castrillo, M. Chen, A. Hoffmann, and P. Tontonoz
Induction of NR4A Orphan Nuclear Receptor Expression in Macrophages in Response to Inflammatory Stimuli
J. Biol. Chem., August 12, 2005; 280(32): 29256 - 29262.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Crespo, J. Martinez-Gonzalez, J. Rius, and L. Badimon
Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation
Cardiovasc Res, August 1, 2005; 67(2): 333 - 341.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Ralph, A. N. McEvoy, D. Kane, B. Bresnihan, O. FitzGerald, and E. P. Murphy
Modulation of Orphan Nuclear Receptor NURR1 Expression by Methotrexate in Human Inflammatory Joint Disease Involves Adenosine A2A Receptor-Mediated Responses
J. Immunol., July 1, 2005; 175(1): 555 - 565.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
K D S. A. Wansa and G. E O Muscat
TRAP220 is modulated by the antineoplastic agent 6-Mercaptopurine, and mediates the activation of the NR4A subgroup of nuclear receptors
J. Mol. Endocrinol., June 1, 2005; 34(3): 835 - 848.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Martinez-Gonzalez and L. Badimon
The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells
Cardiovasc Res, February 15, 2005; 65(3): 609 - 618.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. H. Bassett, T. Suzuki, H. Sasano, C. J. M. de Vries, P. T. Jimenez, B. R. Carr, and W. E. Rainey
The Orphan Nuclear Receptor NGFIB Regulates Transcription of 3{beta}-Hydroxysteroid Dehydrogenase: IMPLICATIONS FOR THE CONTROL OF ADRENAL FUNCTIONAL ZONATION
J. Biol. Chem., September 3, 2004; 279(36): 37622 - 37630.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Lammi, J. Huppunen, and P. Aarnisalo
Regulation of the Osteopontin Gene by the Orphan Nuclear Receptor NURR1 in Osteoblasts
Mol. Endocrinol., June 1, 2004; 18(6): 1546 - 1557.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Rius, J. Martinez-Gonzalez, J. Crespo, and L. Badimon
Involvement of Neuron-Derived Orphan Receptor-1 (NOR-1) in LDL-Induced Mitogenic Stimulus in Vascular Smooth Muscle Cells: Role of CREB
Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 697 - 702.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. K. Arkenbout, M. van Bragt, E. Eldering, C. van Bree, J. M. Grimbergen, P. H.A. Quax, H. Pannekoek, and C. J.M. de Vries
TR3 Orphan Receptor Is Expressed in Vascular Endothelial Cells and Mediates Cell Cycle Arrest
Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1535 - 1540.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. D. S. A. Wansa, J. M. Harris, G. Yan, P. Ordentlich, and G. E. O. Muscat
The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine
J. Biol. Chem., June 27, 2003; 278(27): 24776 - 24790.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Gruber, P. Hufnagl, R. Hofer-Warbinek, J. A. Schmid, J. M. Breuss, R. Huber-Beckmann, M. Lucerna, N. Papac, H. Harant, I. Lindley, et al.
Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNFalpha -induced PAI-1 expression
Blood, April 15, 2003; 101(8): 3042 - 3048.
[Abstract] [Full Text] [PDF]